ArticleTransboundary and emerging diseases2026
An Emerging DTMUV Variant Remains Restricted in Mammals but Acquires Olfactory Route-Mediated Neuroinvasion Following Limited Adaptive Mutations.
Article in Transboundary and emerging diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- An Emerging DTMUV Variant Remains Restricted in Mammals but Acquires Olfactory Route-Mediated Neuroinvasion Following Limited Adaptive Mutations.Transboundary and emerging diseases · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Duck Tembusu virus (DTMUV), a mosquito-borne flavivirus, has caused widespread outbreaks in poultry and has exhibited an expanding host range among avian species, accompanied by ongoing genetic variation and adaptation. As many mosquito-borne flaviviruses can infect mammals and cross species barriers, it remains unclear whether recently emerged DTMUV variants have acquired similar potential. To address this, we assessed whether the circulating variant AQ-19 can establish infection in mammals via peripheral routes. Despite its enhanced virulence in avian species, this variant failed to establish infection in mice following peripheral inoculation, indicating that a substantial barrier still restricts cross-species transmission to mammals. We next investigated whether additional adaptive changes are required for DTMUV to overcome this barrier. Through serial intracranial passage in Institute of Cancer Research (ICR) mice, we generated a mouse-adapted strain (F13) that exhibited markedly enhanced virulence and, notably, acquired the ability to invade the central nervous system (CNS) via intranasal (i.n.) inoculation, resulting in lethal infection. This neuroinvasive phenotype was strictly route-dependent, as infection remained ineffective via intraperitoneal (i.p.) and subcutaneous (s.c.) routes. We found that the adapted virus invades the CNS via the olfactory route and disseminates broadly, exhibiting strong neurotropism and inducing severe neural damage. Functional disruption of the olfactory epithelium using ZnSO
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.